Insights

Loading spinner
Gathering insights about Mirati Therapeutics

Mirati Therapeutics Tech Stack

Mirati Therapeutics uses 8 technology products and services including JReview, ServiceNow Reporting, Qualio, and more. Explore Mirati Therapeutics's tech stack below.

  • JReview
    Analytics
  • ServiceNow Reporting
    Business Intelligence
  • Qualio
    Governance, Risk And Compliance
  • QuantStudio
    Health Platform
  • tcpdump
    Network Management
  • SAP Global Trade Services
    Risk And Compliance
  • Adobe Tag Manager
    Tag Management
  • AJAX
    Web Tools And Plugins

Media & News

Mirati Therapeutics's Email Address Formats

Mirati Therapeutics uses at least 2 format(s):
Mirati Therapeutics Email FormatsExamplePercentage
LastF@mirati.comDoeJ@mirati.com
88%
FLast@mirati.comJDoe@mirati.com
5%
First@mirati.comJohn@mirati.com
3%
Last@mirati.comDoe@mirati.com
4%
First.Last@bms.comJohn.Doe@bms.com
91%
LastF@bms.comDoeJ@bms.com
5%
First@bms.comJohn@bms.com
2%
Last.First@bms.comDoe.John@bms.com
2%

Frequently Asked Questions

Where is Mirati Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Mirati Therapeutics's main headquarters is located at 3545 Cray Court San Diego, California 92121 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Mirati Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Mirati Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Mirati Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Mirati Therapeutics is a publicly traded company; the company's stock symbol is MRTX.

What is Mirati Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Mirati Therapeutics's official website is bms.com and has social profiles on LinkedInCrunchbase.

What is Mirati Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Mirati Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Mirati Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2026, Mirati Therapeutics has approximately 44 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: D. M.Chief Commercial Officer: B. H.Vice President Of Oncology Drug Research: A. X.. Explore Mirati Therapeutics's employee directory with LeadIQ.

What industry does Mirati Therapeutics belong to?

Minus sign iconPlus sign icon
Mirati Therapeutics operates in the Biotechnology Research industry.

What technology does Mirati Therapeutics use?

Minus sign iconPlus sign icon
Mirati Therapeutics's tech stack includes JReviewServiceNow ReportingQualioQuantStudiotcpdumpSAP Global Trade ServicesAdobe Tag ManagerAJAX.

What is Mirati Therapeutics's email format?

Minus sign iconPlus sign icon
Mirati Therapeutics's email format typically follows the pattern of LastF@mirati.com. Find more Mirati Therapeutics email formats with LeadIQ.

How much funding has Mirati Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2026, Mirati Therapeutics has raised $345M in funding. The last funding round occurred on Aug 08, 2023 for $345M.

When was Mirati Therapeutics founded?

Minus sign iconPlus sign icon
Mirati Therapeutics was founded in 2013.

Mirati Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

Mirati Therapeutics, Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies that target the genetic drivers of cancer @Bristol Myers Squibb or www.bms.com

Section iconCompany Overview

Headquarters
3545 Cray Court San Diego, California 92121 United States
Phone number
Website
bms.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MRTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $345M

    Mirati Therapeutics has raised a total of $345M of funding over 8 rounds. Their latest funding round was raised on Aug 08, 2023 in the amount of $345M.

  • $10M$25M

    Mirati Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $345M

    Mirati Therapeutics has raised a total of $345M of funding over 8 rounds. Their latest funding round was raised on Aug 08, 2023 in the amount of $345M.

  • $10M$25M

    Mirati Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.